A new nasal test may allow patients suspected of having lung cancer to undergo a simple swab of their nose to determine if they have the disease. Researchers at Boston University School of Medicine have found that a genomic biomarker in the nasal passage can accurately determine the likelihood of a lung lesion being malignant.
Category: Lung Cancer
Smokers say graphic warnings on cigaret…
Sung Jong-tae, 35, a heavy smoker for the past 15 years, has tried almost everything there is to quit smoking, but his efforts have been in vain. “I am well aware, more than anybody else, of the detrimental effects of smoking, having a 3-year-old daughter at home.
Why Intuitive Surgical Is Increasing R&D Spending by Over 30%
One of the more surprising aspects was the announcement that it planned to increase the amount it spends on research and development in 2017 by an additional $80 million dollars, a full 30% higher than in 2016. Considering that it had already increased R&D spending in 2016 by over 20%, this represents a significant additional investment.
Oncolytics Biotech Inc. Announces 2016 Year-End Results
“Through this process, and with the help of our expanding senior team, we thoughtfully and deliberately put in place a plan that initially contemplates combinations with chemotherapy for late-stage clinical development, but will expand to include targeted immunotherapies over the longer term as we look to leverage the role of the immune system in patient treatment. In the coming months we will specifically define our first registration pathway.